This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
The federal supply schedule contract provides pharmaceuticals and drugs under GSA schedule 65 IB. Awarded by the Department of Veterans Affairs Veterans Health Administration VISN 12, the multiple award contract has a potential value of $225,000. Nnodum Pharmaceuticals Corporation, an 8A certified small disadvantaged minority-owned business, is the prime contractor. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA to support veterans' healthcare...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA Schedule 65 IB. The multiple award contract has a potential value of $750,000 and a period of performance through July 31, 2026. The prime contractor is Myovant Sciences Inc., which will provide drugs, pharmaceuticals, and hematology-related products to support the VA's healthcare services...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to TG Therapeutics Inc. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology related products. With a potential value of $20 million and a period of performance through August 2026, this multiple-award contract aims to procure these medical supplies for VA healthcare...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Aytu Biopharma Inc. for pharmaceuticals and drugs under GSA Schedule 65 IB. With a potential value of $2,942,740 and a period of performance through August 1, 2023, this multiple-award contract provides various pharmaceutical products and hematology-related items to VA medical facilities. The original solicitation sought drugs,...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the Department of Veterans Affairs, to Quest Products, LLC, a for-profit limited liability company. The contract, with a ceiling value of $9,559,570.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a period of performance from March 15, 2024, to March 14, 2029. As a Federal Supply Schedule...
This Federal Supply Schedule contract provides pharmaceuticals and related products to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Awarded on August 15, 2016 to Sebela Pharmaceuticals Inc., it has a potential value of $25.57 million through its period of performance ending March 31, 2024. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule master schedule, identified as FSS-61-IB. It facilitates...